Overview
- The A24‑released documentary earned more than US$15 million in a limited opening on roughly 855–900 screens, finishing second at the North American box office and marking one of the biggest limited documentary debuts in over two decades.
- Directors Nathan Fielder and Lance Oppenheim filmed Elizabeth Holmes and her partner Billy Evans in the weeks before Holmes began serving her 2023 sentence, after working on the project in secret for several years.
- Critics and viewers have given the film unusually high marks, with Rotten Tomatoes approvals near 98–99 percent, a Metacritic score around 99, and a Letterboxd average near 4.8 out of 5.
- The nearly three‑hour runtime (about 174 minutes) and Fielder’s mix of staged and observational techniques have fueled debate over documentary form and ethics while also driving strong audience demand for repeat and sold‑out shows.
- The film’s commercial and critical surge has created early awards‑season conversation and it will expand nationally next weekend, increasing its visibility after a surprise Telluride premiere and years of quiet production; the story also renews interest in Theranos and prior dramatizations of the scandal.